Earn CME: https://www.naccme.com/program/19-lm-06 In this webcast from the ‘New Immunological Approaches to Myeloma: CAR T-Cell Therapy and Other Novel Strategies’ symposium during the 2019 Lymphoma & Myeloma conference in New York, Dr. Sham Mailankody discusses responses to CAR-T therapy in patients with myeloma. © 2019 Imedex, an HMP Company
Responses to CAR-T Therapy in Myeloma
